As shown in triple-negative patient-derived xenograft (PDX) models of breast cancer, pre-metastatic CCL2 niches are enriched in IFNγ-producing CCR2+ monocytes only in nonmetastatic areas. The gene discussed is CCR2; the disease is breast cancer.